Pinealon

Pinealon 10mg

Pinealon is a synthetic short-chain tripeptide developed by Russian peptide research laboratories as part of the broader short-chain regulatory peptide research tradition. With the sequence Glu-Asp-Arg, Pinealon represents one of the short-chain bioregulator peptides characterized by the Khavinson research group and has been studied in cellular biology and biochemical research literature examining cellular gene expression and tissue-specific peptide research.

Product Specifications

• Compound: Pinealon
• Class: Synthetic short-chain tripeptide
• Sequence: Glu-Asp-Arg
• Molecular Weight: ~419 Da
• Form: Lyophilized powder
• Vial Size: 10mg in 3mL glass vial

Research Background

Pinealon has been investigated in research literature across several scientific contexts:

• Short-chain regulatory peptide research — investigations into tripeptide structure-activity relationships and cellular regulatory mechanisms
• Cellular gene expression research — studies examining short-chain peptide effects on gene expression patterns in cellular research models
• Comparative bioregulator peptide research — comparative cellular research positioning Pinealon alongside other Khavinson-group short-chain regulatory peptides (including Cartalax, Epithalon, Prostamax, Cardiogen, Testagen, and Thymagen) in cellular research contexts
• Cellular regulatory peptide research — analytical studies on tripeptide biology and cellular signaling
• Peptide chemistry research — analytical chemistry studies on short-chain peptide stability and biological activity

Pinealon was developed through cellular biology research by the Khavinson research group at the St. Petersburg Institute of Bioregulation and Gerontology, sharing developmental lineage with related short-chain bioregulator peptides studied at the same research institution. Foundational research is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies on short-chain regulatory peptide research.